Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers

BAL8557 is the water-soluble prodrug of a novel antifungal triazole, BAL4815. BAL4815 is active against a broad spectrum of major opportunistic and pathogenic fungi, including strains that are resistant to other azoles. Cohorts of healthy male subjects received single-ascending oral (p.o.) doses of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Schmitt-Hoffmann, Anne, Roos, Brigitte, Heep, Markus, Schleimer, Michael, Weidekamm, Erhard, Brown, Tom, Roehrle, Michael, Beglinger, Christoph
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2006
Assuntos:
Clinical Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1346775/
https://ncbi.nlm.nih.gov/pubmed/16377698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.1.279-285.2006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares